Stock analysis, AI verdict, fundamentals & technical signals
Rating: NEUTRAL
Price: $1.02 Analyst target: $4.00 Upside: 292.16%
Lisata Therapeutics, Inc., a clinical-stage biopharmaceutical company, is focused on developing and commercializing cellular therapies to reverse disease and/or promote regeneration of damaged tissue. The company is headquartered in Basking Ridge, New Jersey.
See the full interactive analysis & chart →Informational only — not investment advice.